LRRK1 and lymphoma: Since immunogenic neoepitopes have not been described for murine lymphoma, we first identified potential MHC I neoepitopes and screened for reactive T cells in ISV-treated mice, and identified T cell responses to mutated Lrrk1, an NFκB driving phosphokinase62 frequently mutated in lymphoma and solid malignancies (cbioportal.org).